Pharmaceutical Executive July 22, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Enhancing Care and Research: Digital Technology’s Impact on Rett Syndrome Management

Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.

Fighting the Flu With Supplements: The Pharmacist’s Patient Counseling Guide

Confusing product labeling and conflicting data can create challenges for patients.

J.D. Vance’s A.I. Agenda: Reduce Regulation

Donald Trump’s vice-presidential pick has indicated he favors a hands-off approach to A.I. but also wants to increase scrutiny of the biggest tech firms in the field.

Global Diabetes and Obesity Therapeutics, 2024 2028: Lucrative Market Opportunities with GLP-1-based Multi-agonists with Improved Tolerability Profile – ResearchAndMarkets.com

The “Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028”...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article